Diadexus, Inc. Stock

DDXSQ

US25245P2056

Pharmaceuticals

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

17/09/21	Diadexus, Inc. Went Out of Business	CI
08/06/18	Motion for Asset Sale Approved for Diadexus, Inc.	CI

Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
DDXSQ Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	49.2K 43.84K 40.59K 36.73K 69.21K 4.64M 70.03K 487K 191K 2.44M 185K 181K 7.78M	P/E 2014	-3.26x	P/E 2015	-1.14x
Enterprise Value	5.29M 4.71M 4.36M 3.95M 7.44M 499M 7.53M 52.33M 20.53M 262M 19.85M 19.43M 836M	EV / Sales 2014	1.05x	EV / Sales 2015	0.77x
Free-Float	100%	Yield 2014 *	-	Yield 2015	-

17/09/21	Diadexus, Inc. Went Out of Business	CI
08/06/18	Motion for Asset Sale Approved for Diadexus, Inc.	CI
09/05/18	Motion for Asset Sale Filed by Diadexus, Inc.	CI
01/08/16	Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
29/07/16	Motion for Asset Sale Approved for Diadexus, Inc.	CI
29/07/16	General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.	CI
20/07/16	Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
07/07/16	Motion for Asset Sale Filed by Diadexus, Inc.	CI
07/07/16	Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.	CI
13/06/16	Diadexus, Inc. Filed for Bankruptcy	CI
11/06/16	Diadexus, Inc. Announces Resignation of Leone Patterson as Chief Financial Office	CI
23/05/16	Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test	CI
30/04/16	Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DIADEXUS, INC.	-.--%	-.--%	-	-	410
ELI LILLY AND COMPANY	-1.01%	+5.13%	+58.93%	+117.36%	1,133B
JOHNSON & JOHNSON	-0.61%	+1.52%	+34.34%	+68.48%	621B
ABBVIE INC.	-1.48%	+0.47%	+23.08%	+94.76%	503B
ROCHE HOLDING AG	-0.48%	+2.61%	+38.89%	+64.01%	379B
MERCK & CO., INC.	+1.07%	+1.70%	+71.06%	+45.98%	370B
NOVARTIS AG	+0.80%	+1.56%	+21.93%	+51.31%	292B
ASTRAZENECA PLC	+0.57%	-0.22%	+1.04%	+25.45%	262B
AMGEN INC.	-0.14%	+2.87%	+45.56%	+57.22%	237B
GILEAD SCIENCES, INC.	-1.88%	+0.02%	+23.77%	+97.39%	190B
Average	+0.40%	+2.89%	+35.40%	+69.11%	398.8B
Weighted average by Cap.	+0.74%	+3.73%	+40.81%	+79.79%

	2014	2015
Net sales	26.11M 23.27M 21.54M 19.5M 36.73M 2.46B 37.17M 258M 101M 1.3B 97.95M 95.91M 4.13B	17.88M 15.94M 14.75M 13.35M 25.16M 1.69B 25.45M 177M 69.41M 887M 67.09M 65.69M 2.83B
Net income	-8.47M -7.54M -6.99M -6.32M -11.91M -799M -12.05M -83.75M -32.86M -420M -31.76M -31.1M -1.34B	-7.17M -6.39M -5.91M -5.35M -10.08M -676M -10.2M -70.88M -27.81M -355M -26.88M -26.32M -1.13B
Net Debt	-198K -176K -163K -148K -279K -18.68M -282K -1.96M -768K -9.82M -743K -727K -31.3M	5.24M 4.67M 4.32M 3.91M 7.37M 495M 7.46M 51.84M 20.34M 260M 19.66M 19.25M 828M

Diadexus, Inc. Stock

Stocks

DDXSQ

US25245P2056

Pharmaceuticals

Valuation: Diadexus, Inc.

Latest news: Diadexus, Inc.

Diagnostic & Testing Substances Manufacturers

Financials

Company Profile